1. Background
2. Methods
2.1. General Information
2.2. Inclusion and Exclusion Criteria
2.3. Survey Methods
2.4. Research Method
2.4.1. Control Group
2.4.2. Study Group
| Operators | Responsible Nurse and Attending Physician | Responsible Nurse and Rehabilitation Specialist | Dietitian |
|---|---|---|---|
| Risk free lower limb crSaO2: 60 - 65% | (1) ensure unobstructed pipelines;(2) avoid twisting, folding, and compression; (3) timing sealing; (4) replace the dressing if necessary. | Guide children to engage in normal activities without disease restrictions. | Maintain a normal diet |
| Low risk lower limb crSaO2: 55 - 59% a | (1) assess whether there is pipeline compression or restricted posture; (2) regularly observe blood circulation, skin color, and swelling; (3) measure the circumference of the lower limbs and record it in the nursing record. If there is a difference of 2 cm in the measured dimensions of both legs, the attending physician should be notified immediately. | Regularly roll over: Roll over every 2 hours and maintain the position for 30 minutes once | 28 d – 18 m children: Regular infant formula powder, residue free complementary food; Children ≥ 19 m: Partial oral feeding, partial nutrient support with enteral nutrition |
| Moderate risk lower limb crSaO2: 50 - 54% b | (1) is there a low body temperature? If the body temperature is less than 36.0℃, a hat or hand and foot warmer should be worn, and a care towel should be used to cover the abdomen and lower limbs; (2) for the infusion liquid, keep it at a constant temperature of 37.0℃. | Local massage: Spread a massage towel on the surface of the Gastrocnemius muscle skin of both legs, slowly massage from the foot tip to the lower leg to the knee joint, 30 - 50 times each time, twice a day. | 28 d – 18 m children: Regular infant formula powder, residue free complementary food; Children ≥ 19 m: Adjust the amount of enteral and parenteral nutrition support according to the digestive status of the child |
| High risk lower limb crSaO2: 45 - 49% c | (1) anticoagulant therapy (2) warfarin treatment | Passive movement: Slowly press down on the foot surface to hold the action for 5 seconds; rest for 1 - 2 seconds; press the foot up and hold for 5 seconds; rest for 1 - 2 seconds; rotate left and right and hold for 5 seconds, rest for 1 -2 seconds. 30 - 50 times per session, 2 - 3 times per day | 28 d – 18 m children: Regular infant formula powder, residue free complementary food; Children ≥ 19 m: complete parenteral nutrition support |
a Low risk lower limb crSaO2: 55 - 65%.
bModerate risk lower limb crSaO2: 45 - 55%.
c High risk lower limb crSaO2: 35 - 46%.
2.5. Observed Indicators
2.5.1. Biochemical Examination
2.5.2. Symptoms Related to Lower Limb Deep Vein Thrombosis
2.6. Quality Control
2.7. Data Collection
2.8. Statistical Analysis
3. Results
3.1. Single Factor Analysis of Deep Vein Thrombosis in Critically Ill Children Undergoing Catheterization
| Indicators | DVT Group (N = 20) | Non-DVT Group (N = 60) | P | |
|---|---|---|---|---|
| Gender | 0.017 | 0.897 | ||
| Male | 11 | 32 | ||
| Female | 9 | 28 | ||
| Age of years | 8.51 ± 1.46 | 7.95 ± 2.01 | 1.147 | 0.255 |
| Puncture site | 0.818 | 0.664 | ||
| Femoral vein | 18 | 57 | ||
| Jugular vein | 1 | 2 | ||
| Sub-clavian vein | 1 | 1 | ||
| Conduit model | 3.118 | 0.210 | ||
| 6F | 3 | 19 | ||
| 8F | 4 | 15 | ||
| 11F | 13 | 26 | ||
| BMI (kg/m2) | 17.35 ± 2.01 | 18.01 ± 1.16 | 1.807 | 0.075 |
| Bed rest time (d) | 4.689 | 0.030 | ||
| < 3 | 3 | 25 | ||
| ≥ 3 | 17 | 35 | ||
| Limb braking | 7.742 | 0.005 | ||
| Yes | 13 | 18 | ||
| No | 7 | 42 | ||
| ALB (g/L) | 35.38 ± 2.16 | 36.23 ± 0.51 | 2.851 | 0.006 |
| WBC (×109/L) | 9.41 ± 1.39 | 7.42 ± 2.24 | 2.044 | 0.044 |
| FIB (g/L) | 3.89 ± 1.19 | 2.55 ± 1.65 | 3.347 | 0.001 |
| D-D(mg/L) | 15.21 ± 2.13 | 14.09 ± 1.16 | 2.988 | 0.004 |
Abbreviations: DVT, deep vein thrombosis; BMI, Body Mass Index; ALB, albumin; WBC, white blood cell; FIB, fibrinogen; D-D, D-dimer.
a Values are expressed as No (%) or mean ± SD.
3.2. Logistic Regression Analysis of Deep Vein Thrombosis in Critically Ill Children with Catheterization
| Variables | Assigned Method |
|---|---|
| Dependent variable | DVT in critically ill children with catheterization |
| Independent variable | |
| Bed time | < 3 = 0, ≥ 3 = 1 |
| Limb braking | No = 0, Yes = 1 |
| WBC | Input with original value |
| FIB | Input with original value |
| D-D | Input with original value |
| ALB | Input with original value |
Abbreviations: DVT, deep vein thrombosis; ALB, albumin; WBC, white blood cell; FIB, fibrinogen; D-D, D-dimer.
3.3. Logistic Regression Analysis on the Impact of Deep Vein Thrombosis on Critically Ill Children
| Projects | B | S.E. | Wald χ2 | P | OR | 95% CI | |
|---|---|---|---|---|---|---|---|
| Lower Limit | Upper Limit | ||||||
| Constant | -23.267 | 9.998 | 5.416 | 0.020 | 0.000 | - | - |
| Bed time ≥ 3 days | 1.086 | 0.428 | 6.452 | 0.011 | 2.963 | 1.282 | 6.852 |
| Limb braking | 1.045 | 0.436 | 5.735 | 0.017 | 2.843 | 1.209 | 6.685 |
| FIB | 4.056 | 0.832 | 23.764 | < 0.001 | 57.765 | 11.308 | 295.094 |
| D-D | 1.228 | 0.457 | 7.236 | 0.007 | 3.415 | 1.396 | 8.359 |
Abbreviations: FIB, fibrinogen; D-D, D-dimer, OR, odds ratio; CI, confidence interval.
3.4. Comparison of Four Coagulation Indicators Between Two Groups of Patients at Different Time Periods
| Divisions | No. | T0 | T1 | T2 |
|---|---|---|---|---|
| TT (s) b | ||||
| Study group | 30 | 19.72 ± 2.18 | 15.23 ± 1.41 | 14.22 ± 1.20 |
| Control group | 30 | 19.29 ± 2.51 | 16.01±1.19 | 15.29 ± 1.27 |
| χ2/t | 0.708 | 2.316 | 3.354 | |
| P | 0.482 | 0.024 | 0.001 | |
| APTT (s) c | ||||
| Study group | 30 | 30.71 ± 1.19 | 26.34 ± 1.52 | 23.21 ± 1.28 |
| Control group | 30 | 30.27 ± 2.01 | 27.21 ± 1.09 | 24.65 ± 2.11 |
| χ2/t | 1.054 | 2.548 | 3.310 | |
| P | 0.296 | 0.014 | 0.002 | |
| FIB (g/L) d | ||||
| Study group | 30 | 2.95 ± 0.56 | 5.56 ± 0.40 | 5.09 ± 0.46 |
| Control group | 30 | 2.79 ± 0.41 | 5.35±0.21 | 5.91 ± 1.26 |
| χ2/t | 1.263 | 2.546 | 3.348 | |
| P | 0.212 | 0.014 | 0.001 | |
| D-D (mg/L) e | ||||
| Study group | 30 | 8.26 ± 0.54 | 6.09 ± 0.31 | 4.62 ± 0.69 |
| Control group | 30 | 8.34 ± 1.21 | 6.51 ± 0.94 | 5.49 ± 1.11 |
| χ2/t | 0.331 | 2.324 | 3.646 | |
| P | 0.742 | 0.024 | 0.001 |
Abbreviations: TT, thrombin time; APTT, activated partial thromboplastin time; FIB, fibrinogen; D-D, D-dimer.
aValues are expressed as mean ± SD unless otherwise indicated.
b TT: F division /F intra-group /F interaction = 63.853/388.309/23.147, P division /P intra-group /P interaction = < 0.001/ < 0.001/ < 0.001.
c APTT: F division /F intra-group /F interaction = 32.190/208.896/13.929, P division /P intra-group /P interaction = < 0.001/ < 0.001/ < 0.001.
d FIB: F division /F intra-group /F interaction = 7.561/1932.894/61.723, P division /P intra-group /P interaction = 0.007/ < 0.001/ < 0.001.
e D-D: F division /F intra-group /F interaction = 11.237/954.007/144.597, P division /P intra-group /P interaction = 0.001/ < 0.001/ < 0.001.
3.5. Comparison of Lower Limb Deep Vein Thrombosis Related Symptoms Between Two Groups of Patients
| Divisions | N | Calf PAin | Skin Flushing | Elevated Skin Temperature | Limb Swelling | Limb Stiffness | Total Occurrence Rate |
|---|---|---|---|---|---|---|---|
| Study group | 30 | 1 (3.33) | 1 (3.33) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 2 (6.67) |
| Control group | 30 | 2 (6.67) | 3 (10.00) | 2 (6.67) | 2 (6.67) | 1 (3.33) | 10 (33.33) |
a Values are expressed as No (%).
b χ2 = 5.104; P = 0.024.



